Abstract
Lithium, an old and invaluable psychiatric therapy, is still the best treatment option in several clinical circumstances, including acute mania, bipolar and unipolar recurrent mood disorders, suicidal ideation and behavior, recurrent or chronic unipolar depression that has not responded to other treatments, aggressive or impulsive behavior and alcoholism, especially when an affective component is manifest. However, lithium has a narrow therapeutic index and is associated with many serious acute and long-term side effects. Furthermore, monitoring requirements, i.e., frequent blood draws and frequent visits, discourage lithium use. Therefore, the drug is underused. Full awareness of lithium side effects and competence to minimize them is the only contrast to this ominous trend. Renal side effects are frequent in the course of lithium treatment. Although not serious in the large majority of cases, they may seldom become severe and result in chronic renal failure and end stage renal disease. The aim of the paper is reviewing the renal safety profile of lithium and the suggested strategies in the management of the lithium associated renal side effects.
Keywords: Bipolar disorder, lithium, side effects, suicide, treatment, unipolar recurrent mood disorders, NEPHROGENIC DIABETES INSIPIDUS, ACUTE LITHIUM INTOXICATION
Current Drug Safety
Title: Lithium and Kidney, 60 Years Later
Volume: 6 Issue: 5
Author(s): Michele Raja
Affiliation:
Keywords: Bipolar disorder, lithium, side effects, suicide, treatment, unipolar recurrent mood disorders, NEPHROGENIC DIABETES INSIPIDUS, ACUTE LITHIUM INTOXICATION
Abstract: Lithium, an old and invaluable psychiatric therapy, is still the best treatment option in several clinical circumstances, including acute mania, bipolar and unipolar recurrent mood disorders, suicidal ideation and behavior, recurrent or chronic unipolar depression that has not responded to other treatments, aggressive or impulsive behavior and alcoholism, especially when an affective component is manifest. However, lithium has a narrow therapeutic index and is associated with many serious acute and long-term side effects. Furthermore, monitoring requirements, i.e., frequent blood draws and frequent visits, discourage lithium use. Therefore, the drug is underused. Full awareness of lithium side effects and competence to minimize them is the only contrast to this ominous trend. Renal side effects are frequent in the course of lithium treatment. Although not serious in the large majority of cases, they may seldom become severe and result in chronic renal failure and end stage renal disease. The aim of the paper is reviewing the renal safety profile of lithium and the suggested strategies in the management of the lithium associated renal side effects.
Export Options
About this article
Cite this article as:
Raja Michele, Lithium and Kidney, 60 Years Later, Current Drug Safety 2011; 6 (5) . https://dx.doi.org/10.2174/157488611798918737
DOI https://dx.doi.org/10.2174/157488611798918737 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Unaddressed Issue of Optimal Antithrombotic Treatment after Coronary Artery Stenting in Patients with an Indication for Anticoagulation: Current Evidence and Suggested Practice
Vascular Disease Prevention (Discontinued) Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Thiazolidinediones
Current Drug Safety Pharmacological Activity of Cardiovascular Agents from Herbal Medicine
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Editorial [Hot Topic: A New Era of Gene Therapy]
Current Topics in Medicinal Chemistry Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
Current Vascular Pharmacology Central Arterial Aging and Angiotensin II Signaling
Current Hypertension Reviews Neuroimmunomodulation and Aging: A Role for Transferrin and the Hypothalamus/Thymus Axis
Current Aging Science Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Current Diabetes Reviews Patent Selections:
Recent Patents on Medical Imaging Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Potential New Targets for Antithrombotic Therapy
Current Pharmaceutical Design Gene Therapy in Cardiovascular Diseases
Current Gene Therapy Biomedical Nano Tools: A Potential New Paradigm for Immunoassays and Immune Detection
Current Nanomedicine Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
Current Diabetes Reviews Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropathy, Proteinuria Estimation, Diagnosing and Monitoring
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Protein Z and Ischemic Stroke
Vascular Disease Prevention (Discontinued) Genistein: A Phytoestrogen with Multifaceted Therapeutic Properties
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Trends in Vascular Biology; Functional Restoration of Damaged Endothelium (Executive Editors: J.A. Rodriguez-Feo and G. Pasterkamp)]
Current Pharmaceutical Design